Clinical Trial Update: OH2 Oncolytic Viral Therapy in Central Nervous System Tumors [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial of OH2 Oncolytic Viral Therapy for central nervous system tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Tumors

Drugs mentioned

• OH2 Oncolytic Viral Therapy

Snippet

Sponsor: Binhui Biopharmaceutical Co., Ltd. | Conditions: Central Nervous System Tumors | Phase 1, Phase 2 | Status: RECRUITING